Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 12Breast Neoplasms 12Pain 11Neoplasms 10Pain, Postoperative 9Prostatic Neoplasms 7Lung Neoplasms 6Agnosia 6Colonic Neoplasms 5Neuralgia 4Keratosis, Actinic 4Cancer Pain 4Liver Neoplasms 3Leiomyoma 3Head and Neck Neoplasms 3Chronic Pain 3Thyroid Neoplasms 2Stomach Neoplasms 2Pilonidal Sinus 2Oropharyngeal Neoplasms 2Neuroma 2Neoplasm Metastasis 2Myofibroma 2Inflammatory Bowel Diseases 2Ileus 2Diverticulitis 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urinary Bladder Neoplasms 1

Interventions

Lidocaine 1Folfox protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cold Hypersensitivity × Lidocaine × Clear all
NCT03254394 2022-03-09

Lidocaine for Oxaliplatin-induced Neuropathy

Washington University School of Medicine

Phase 1/2 Completed
26 enrolled 10 charts
Gastrointestinal

Neuropathy, Painful, Cold Hypersensitivity, Neuralgia, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡